164 related articles for article (PubMed ID: 23054103)
1. Utilization of sentinel lymph node biopsy in patients with ductal carcinoma in situ undergoing mastectomy.
Shah DR; Canter RJ; Khatri VP; Bold RJ; Yang AD; Martinez SR
Ann Surg Oncol; 2013 Jan; 20(1):24-30. PubMed ID: 23054103
[TBL] [Abstract][Full Text] [Related]
2. Is Sentinel Lymph Node Biopsy Necessary for Ductal Carcinoma In Situ Patients Undergoing Mastectomy?
Miller-Ocuin JL; Howard-McNatt M; Levine EA; Chiba A
Am Surg; 2020 Aug; 86(8):955-957. PubMed ID: 32862671
[TBL] [Abstract][Full Text] [Related]
3. Predictors of invasive breast cancer in patients with an initial diagnosis of ductal carcinoma in situ: a guide to selective use of sentinel lymph node biopsy in management of ductal carcinoma in situ.
Yen TW; Hunt KK; Ross MI; Mirza NQ; Babiera GV; Meric-Bernstam F; Singletary SE; Symmans WF; Giordano SH; Feig BW; Ames FC; Kuerer HM
J Am Coll Surg; 2005 Apr; 200(4):516-26. PubMed ID: 15804465
[TBL] [Abstract][Full Text] [Related]
4. Predictors of treatment with mastectomy, use of sentinel lymph node biopsy and upstaging to invasive cancer in patients diagnosed with breast ductal carcinoma in situ (DCIS) on core biopsy.
Chin-Lenn L; Mack LA; Temple W; Cherniak W; Quinn RR; Ravani P; Lewin AM; Quan ML
Ann Surg Oncol; 2014 Jan; 21(1):66-73. PubMed ID: 24046105
[TBL] [Abstract][Full Text] [Related]
5. Necessity of sentinel lymph node biopsy in ductal carcinoma in situ patients: a retrospective analysis.
Shin YD; Lee HM; Choi YJ
BMC Surg; 2021 Mar; 21(1):159. PubMed ID: 33752671
[TBL] [Abstract][Full Text] [Related]
6. The Influence of Hospital and Surgeon Factors on the Prevalence of Axillary Lymph Node Evaluation in Ductal Carcinoma In Situ.
Coromilas EJ; Wright JD; Huang Y; Feldman S; Neugut AI; Chen L; Hershman DL
JAMA Oncol; 2015 Jun; 1(3):323-32. PubMed ID: 26181180
[TBL] [Abstract][Full Text] [Related]
7. Does sentinel lymph node biopsy for screening high-grade ductal carcinoma in situ of the breast cause more harm than good?
Ramzi S; Najeeb E; Coulthard J; Jenkins S
Breast Cancer Res Treat; 2020 Jul; 182(1):47-54. PubMed ID: 32430678
[TBL] [Abstract][Full Text] [Related]
8. Utilization of lymph node assessment in patients with ductal carcinoma in situ treated with lumpectomy.
Shah DR; Canter RJ; Khatri VP; Bold RJ; Martinez SR
J Surg Res; 2012 Sep; 177(1):e21-6. PubMed ID: 22482771
[TBL] [Abstract][Full Text] [Related]
9. Role of sentinel lymph node biopsy in ductal carcinoma-in-situ treated by mastectomy.
Tan JC; McCready DR; Easson AM; Leong WL
Ann Surg Oncol; 2007 Feb; 14(2):638-45. PubMed ID: 17103256
[TBL] [Abstract][Full Text] [Related]
10. Sentinel lymph node positivity in patients undergoing mastectomies for ductal carcinoma in situ (DCIS).
Price A; Schnabel F; Chun J; Kaplowitz E; Goodgal J; Guth A; Axelrod D; Shapiro R; Mema E; Moy L; Darvishian F; Roses D
Breast J; 2020 May; 26(5):931-936. PubMed ID: 31957944
[TBL] [Abstract][Full Text] [Related]
11. Sentinel lymph node biopsy in contralateral prophylactic mastectomy: are we overtreating? Experience at a tertiary care hospital.
Kuwajerwala NK; Dekhne NS; Pentiak PA; Fend D; Callahan RE; Amine M; Lucia V; Swartz J
Clin Breast Cancer; 2013 Aug; 13(4):287-91. PubMed ID: 23706482
[TBL] [Abstract][Full Text] [Related]
12. Utilization of Axillary Surgery for Patients With Ductal Carcinoma In Situ: A Report From the National Cancer Data Base.
Miller ME; Kyrillos A; Yao K; Kantor O; Tseng J; Winchester DJ; Shulman LN
Ann Surg Oncol; 2016 Oct; 23(10):3337-46. PubMed ID: 27334212
[TBL] [Abstract][Full Text] [Related]
13. Predictive factors of axillary positive sentinel lymph node biopsy in extended ductal carcinoma in situ treated by simple mastectomy at once.
Hotton J; Salleron J; Rauch P; Buhler J; Pierret M; Baumard F; Leufflen L; Marchal F
J Gynecol Obstet Hum Reprod; 2020 Mar; 49(3):101641. PubMed ID: 31562936
[TBL] [Abstract][Full Text] [Related]
14. The use of sentinel lymph node biopsy in the treatment of breast ductal carcinoma in situ: A Danish population-based study.
Holm-Rasmussen EV; Jensen MB; Balslev E; Kroman N; Tvedskov TF
Eur J Cancer; 2017 Dec; 87():1-9. PubMed ID: 29096155
[TBL] [Abstract][Full Text] [Related]
15. Sentinel lymph node biopsy can be omitted in DCIS patients treated with breast conserving therapy.
van Roozendaal LM; Goorts B; Klinkert M; Keymeulen KBMI; De Vries B; Strobbe LJA; Wauters CAP; van Riet YE; Degreef E; Rutgers EJT; Wesseling J; Smidt ML
Breast Cancer Res Treat; 2016 Apr; 156(3):517-525. PubMed ID: 27083179
[TBL] [Abstract][Full Text] [Related]
16. Disparities and trends in sentinel lymph node biopsy among early-stage breast cancer patients (1998-2005).
Chen AY; Halpern MT; Schrag NM; Stewart A; Leitch M; Ward E
J Natl Cancer Inst; 2008 Apr; 100(7):462-74. PubMed ID: 18364506
[TBL] [Abstract][Full Text] [Related]
17. Is routine sentinel lymph node biopsy indicated in women undergoing contralateral prophylactic mastectomy? Magee-Womens Hospital experience.
Soran A; Falk J; Bonaventura M; Keenan D; Ahrendt G; Johnson R
Ann Surg Oncol; 2007 Feb; 14(2):646-51. PubMed ID: 17122987
[TBL] [Abstract][Full Text] [Related]
18. Factors associated with lymph node assessment in ductal carcinoma in situ: analysis of 1988-2002 seer data.
Porembka MR; Abraham RL; Sefko JA; Deshpande AD; Jeffe DB; Margenthaler JA
Ann Surg Oncol; 2008 Oct; 15(10):2709-19. PubMed ID: 18483831
[TBL] [Abstract][Full Text] [Related]
19. A N0 Predicting Model for Sentinel Lymph Node Biopsy Omission in Early Breast Cancer Upstaged From Ductal Carcinoma in Situ.
Yoo TK; Kim SJ; Lee J; Lee SB; Lee SJ; Park HY; Park HK; Chae BJ; Eom YH; Kim HS; Song BJ
Clin Breast Cancer; 2020 Jun; 20(3):e281-e289. PubMed ID: 32147404
[TBL] [Abstract][Full Text] [Related]
20. Selective omission of sentinel lymph node biopsy in mastectomy for ductal carcinoma in situ: identifying eligible candidates.
Bae SJ; Kook Y; Jang JS; Baek SH; Moon S; Kim JH; Lee SE; Kim MJ; Ahn SG; Jeong J
Breast Cancer Res; 2024 Apr; 26(1):65. PubMed ID: 38609935
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
